Loading...
UG is not a good buy right now. The stock is technically extended (RSI overbought) near resistance while fundamentals are deteriorating sharply (big YoY declines in revenue, net income, EPS, and gross margin). With no Intellectia buy signals and a statistically negative next-week/next-month drift, the risk/reward for an impatient buyer is unattractive—avoid new entries here (or trim/sell if already holding).
Price/Trend: Momentum is improving short-term (MACD histogram +0.08 and expanding), and moving averages are converging (transition phase rather than a clean, durable uptrend). Overbought: RSI(6) = 83.04 signals the move is stretched and vulnerable to pullback. Levels: Pivot 6.765. Resistance R1 7.185 and R2 7.444; post-market is ~7.20, i.e., slightly above R1—often a spot where breakouts fail without strong catalysts. Support S1 6.344 then S2 6.085. Pattern-based odds: Similar-pattern projection shows ~0.09% next day, -2.87% next week, -10.89% next month—tilting bearish for a near-term entry.
Intellectia Proprietary Trading Signals
and pushes toward 7.444 (R
with volume, a brief continuation pop is possible.
near resistance increases pullback risk.
Latest quarter: 2025/Q3. Revenue fell to 2,264,261 (-26.01% YoY). Net income fell to 268,441 (-68.98% YoY). EPS fell to 0.06 (-68.42% YoY). Gross margin dropped to 42.09 (-22.00% YoY). Overall: clear deceleration and margin compression, which undermines the durability of any technical bounce.
No analyst rating or price target change data was provided, so there is no observable recent trend to summarize. Without Street coverage details, the practical pro/con setup from Wall Street cannot be validated; given the sharp YoY declines in the latest quarter, the fundamental 'con' case currently dominates based on available data.
